Ophthalmology sponsored testing program

Invitae partners with biopharma companies to offer sponsored testing for patients who meet eligibility criteria

Inherited Retinal Disease Gene Testing Program

Invitae is offering a Spark-sponsored genetic testing program at no charge* for individuals suspected of having inherited retinal disease (IRD). This program gives patients access to a broad genetic testing panel of approximately 250 genes associated with IRDs.

IRDs are a group of rare eye disorders caused by an inherited gene mutation and can result in vision loss or blindness. Common IRDs include retinitis pigmentosa, choroideremia, Leber congenital amaurosis, cone-rod dystrophy, and juvenile macular degeneration.

*This initiative is open to U.S. residents only, subject to the Terms and Conditions of the program.